戻る Agenda
Session 3
Speaker(s)
![Satoshi Shibusawa](/_Images/member/Generic_Image_Missing-Profile.jpg)
Satoshi Shibusawa
Mitsubishi Tanabe Pharma Corporation, Japan
Clincial Operation, Clinical Research & Development I
Taiji Yamasaki
Merck & Co., Inc., Japan
Senior Director, Study Management
![Kosuke Itagaki, MBA, MPH, RPh](/_Images/member/Generic_Image_Missing-Profile.jpg)
Presentation3-1
Kosuke Itagaki, MBA, MPH, RPh
Daiichi Sankyo, Inc, United States
Global Development Information Management, R&D Strategy & Operations
![Chika Kaneko](/_Images/member/Generic_Image_Missing-Profile.jpg)
Presentation3-2
Chika Kaneko
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Office of Non-clinical and Clinical Compliance II
Hironori Seto
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Senior Scientist, Office of Non-clinical and Clinical Compliance ?
![Reiko Tsushima](/_Images/member/Generic_Image_Missing-Profile.jpg)
Reiko Tsushima
Bristol Myers Squibb, Japan
Global Development Operations, Regional Clinical Compliance Lead for Japan
![Yoshinobu Fukatsu](/_Images/member/Generic_Image_Missing-Profile.jpg)
Yoshinobu Fukatsu
EPS Corporation, Japan
Clinical Development Business Headquarters, Clinical Operations Center
![Keiko Yamamoto](/_Images/member/Generic_Image_Missing-Profile.jpg)
Keiko Yamamoto
National Cancer Center Hospital East, Japan
Clinical Research Support Office